Hongkou Capital
Overview
Hongkou Capital is a private equity firm that prefers to invest through means of buyouts and growth capital . The firm prefers to invest in B2C, electronics, and cleantech sectors and is a Registered Investment Adviser (RIA) .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Kriya Therapeutics | Jul 2021 | Series B | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Hongkou Capital based?
Hongkou Capital is headquartered in New York City, New York, United States.
When was Hongkou Capital founded?
Hongkou Capital was founded in 2020.
How many portfolio companies does Hongkou Capital have?
Hongkou Capital has 1 portfolio company in Caplight's dataset.
What are some companies in Hongkou Capital's portfolio?
Portfolio companies visible on Caplight include Kriya Therapeutics.
What was Hongkou Capital's most recent investment shown here?
Hongkou Capital's most recent investment in this portfolio sample was in Kriya Therapeutics in 2021.
What sectors does Hongkou Capital focus on?
Hongkou Capital focuses on Healthcare & Life Sciences.
What company stages does Hongkou Capital focus on?
Hongkou Capital typically invests at the Mid stage.
What is Hongkou Capital's AUM?
Hongkou Capital's assets under management are estimated between $250.0M and $500.0M.